Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Graphite Bio Inc (NQ: GRPH ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Mar 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Graphite Bio Inc < Previous 1 2 3 4 5 Next > 12 Health Care Stocks Moving In Friday's Intraday Session February 18, 2022 Gainers HOOKIPA Pharma (NASDAQ:HOOK) stock moved upwards by 27.0% to $2.54 during Friday's regular session. The current volume of 40.0 million shares is 1123.6% of... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For February 18, 2022 February 18, 2022 Upgrades Roth Capital upgraded the previous rating for Denbury Inc (NYSE:DEN) from Neutral to Buy. For the third quarter, Denbury had an EPS of $0.74, compared to year-ago... Via Benzinga Graphite Bio Announces Participation in Upcoming Investor Conferences January 27, 2022 From Graphite Bio, Inc. Via Business Wire 3 Stocks Insiders Are Buying: Oracle, Consumer Portfolio Services And More January 24, 2022 Although Dow Jones dipped more than 700 points this morning, there were a few notable insider buys. When insiders purchase shares, it ind... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session January 19, 2022 Gainers Zogenix (NASDAQ:ZGNX) shares moved upwards by 67.2% to $26.15 during Wednesday's regular session. As of 12:30 EST, Zogenix's stock is trading at a volume... Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session January 07, 2022 Gainers ContraFect (NASDAQ:CFRX) stock mo... Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session January 06, 2022 Gainers ContraFect (NASDAQ:CFRX) stock in... Via Benzinga Graphite Bio Presents Overview of Phase 1/2 CEDAR Trial Evaluating Investigational Gene Editing Therapy GPH101 in Sickle Cell Disease at 63rd ASH Annual Meeting and Exposition December 11, 2021 From Graphite Bio, Inc. Via Business Wire Graphite Bio to Host Key Opinion Leader Webinar on Gene Correction for Sickle Cell Disease December 07, 2021 From Graphite Bio, Inc. Via Business Wire Graphite Bio Enrolls First Patient in Phase 1/2 Clinical Trial of GPH101 for Sickle Cell Disease November 17, 2021 From Graphite Bio, Inc. Via Business Wire 61 Biggest Movers From Yesterday November 23, 2021 Gainers Longeveron Inc. (NASDAQ: LGVN) shares surged 181.2% to settle at $28.20 on Monday on continued upward momentum after the company last week announced the FDA granted Rare... Via Benzinga Exposures Product Safety Graphite Bio Reports Recent Business Progress and Third Quarter 2021 Financial Results November 10, 2021 From Graphite Bio, Inc. Via Business Wire Graphite Bio Announces Presentation on Phase 1/2 CEDAR Trial of GPH101 in Sickle Cell Disease at Upcoming 63rd ASH Annual Meeting and Exposition November 04, 2021 From Graphite Bio, Inc. Via Business Wire Graphite Bio Announces Participation in Upcoming Jefferies Gene Therapy/Editing Summit October 21, 2021 From Graphite Bio, Inc. Via Business Wire 3 Stocks Insiders Are Buying October 18, 2021 When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go... Via Benzinga Graphite Bio Presents Preclinical Data Supporting GPH101 in Sickle Cell Disease at 49th Annual Sickle Cell Disease Association of America National Convention October 12, 2021 From Graphite Bio, Inc. Via Business Wire The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs October 08, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results October 07, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc... Via Benzinga The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal October 06, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (... Via Benzinga Graphite Bio Announces Upcoming Presentation at 49th Annual Sickle Cell Disease Association of America National Convention October 05, 2021 From Graphite Bio, Inc. Via Business Wire The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data September 23, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 22) Acceleron Pharma Inc. (... Via Benzinga Exposures COVID-19 Graphite Bio Announces Participation in Upcoming September Investor Conferences August 30, 2021 From Graphite Bio, Inc. Via Business Wire Graphite Bio Reports Recent Business Progress and Second Quarter 2021 Financial Results August 12, 2021 From Graphite Bio, Inc. Via Business Wire 12 Health Care Stocks Moving In Friday's Pre-Market Session August 06, 2021 Gainers Applied Molecular (NASDAQ:AMTI) shares increased by 19.38% to $35.54 during Friday's pre-market session. The market value of their outstanding shares is at $1.... Via Benzinga Graphite Bio's Approach To Gene Editing Has BofA Securities and Morgan Stanley Bullish July 20, 2021 A differentiated approach to gene editing has ushered a bullish sentiment from BofA Securities and Morgan Stanley on Graphite Bio, Inc... Via Benzinga The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data August 20, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS... Via Benzinga Exposures COVID-19 Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2021 July 20, 2021 Upgrades For Bank of Marin Bancorp (NASDAQ: Via Benzinga Opening Day: Wahlberg-backed Gym Owner F45 Opens Higher In Public Debut July 18, 2021 Mark Wahlberg-backed F45 Training rose as much as 11% in its trading debut but fell near the offer price after its $325M IPO on Thursday. The listing was delayed by the COVID-19 pandemic and then... Via Talk Markets Topics Initial Public Offering Exposures COVID-19 Securities Market The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs July 18, 2021 Biotech stocks were down for a second week in a row, as they retreated along with the broader market amid macro concerns. Consumer price inflation data released during the week... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts July 01, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 30) Ambrx Biopharma Inc. (NYSE... Via Benzinga Exposures Product Safety < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.